Kalarus Z, Prokopczuk J, Krupa H, Rowiński A, Musialik-Lydka A, Pasyk S
I Katedry i Kliniki Kardiologii, Slaskiej Akademii Medycznej.
Przegl Lek. 1997;54(1):43-5.
Arrhythmogenic right ventricular dysplasia (ARVD) is a heart muscle disease in which muscle tissue has been partially replaced by adipose or fibro-adipose tissue. Morphologic changes in the right ventricle and ventricular arrhythmias are characteristic. Pathomorphological changes should be confirmed by NMR or endomyocardial biopsy. Morphological changes ought to be found by ultrasound methods or angiographic examination. ECG exercise test, Holter monitoring, late potentials, total ventricular activation time and programmed stimulation of right ventricle are used to evaluate the risk of sudden death due to ventricular arrhythmias which is the most important problem. Those methods indicate pharmacologic or invasive therapy (RF ablation, implanted cardioverter-defibrillators), and are used to establish the effectiveness of treatment.
致心律失常性右室心肌病(ARVD)是一种心肌疾病,其中肌肉组织已部分被脂肪或纤维脂肪组织取代。右心室的形态学改变和室性心律失常是其特征。病理形态学改变应由核磁共振成像(NMR)或心内膜活检来证实。形态学改变应通过超声方法或血管造影检查来发现。心电图运动试验、动态心电图监测、晚电位、心室总激活时间以及右心室程控刺激用于评估因室性心律失常导致的猝死风险,这是最重要的问题。这些方法可指导药物治疗或侵入性治疗(射频消融、植入式心脏复律除颤器),并用于确定治疗效果。